Page results
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
The Maternal Medicine team provides care for women with pre-existing medical disorders or pregnancy-related medical conditions. We work in a multidisciplinary team of doctors and midwives in order to provide the best standard of care for women and their babies.
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
This page provides information about anaesthesia for children having proton beam therapy.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
This page provides information about the thermoregulatory sweat test (TST).
-
Concerned about the impact of climate change on people with neurological conditions, Professor Sanjay Sisodiya has established established a consortium of neurological specialists and will be undertaking research.
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
File results
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication